3rd Shift Quality Control Analyst (GMP)

JMD Technologies Inc.; Boston (MA); On-site; USD 55,104 - 68,880; Full time

Job summary

JMD Technologies Inc. in Boston seeks a Quality Control Analyst to support QC operations on the 3rd shift, helping validate, test, and report on in-process, release, and stability samples in a cGMP environment.

The role emphasizes meticulous data handling, adherence to cGMP and cGDP, and collaboration with the team to troubleshoot methods and maintain electronic records. Experience with LIMS and lab software is preferred, and the successful candidate will work closely with QA, manufacturing, and

Qualifications

• Bachelor's degree in biology, chemistry, biochemistry, or related science.
• 2–6 years of GMP pharmaceutical/biopharmaceutical experience.
• Demonstrated laboratory experience in multiple methodologies listed in responsibilities.

Responsibilities

• Perform tests including flow cytometry, cell counting, cell culture, sterility (BACT), endotoxin (LAL), and Visual Inspection.
• Submit technical reviews of raw data.
• Record test results and maintain raw data and accurate lab records.
• Perform general lab and equipment maintenance duties.
• Take part in troubleshooting analytical methods and Quality Events (Deviations, OOS).
• Adhere to cGMP and cGDP principles and maintain equipment and notebooks.

Skills

Attention to detail

Team player

cGMP knowledge

Data handling

Laboratory basics

Electronic lab notebook (LIMS)

Education

Bachelor's degree in science

Tools

LIMS

Job description

JMD Technologies Inc. in Boston seeks a Quality Control Analyst to support QC operations on the 3rd shift, helping validate, test, and report on in-process, release, and stability samples in a cGMP environment.

The role emphasizes meticulous data handling, adherence to cGMP and cGDP, and collaboration with the team to troubleshoot methods and maintain electronic records. Experience with LIMS and lab software is preferred, and the successful candidate will work closely with QA, manufacturing, and